Skip to main content
OpenTrials
Completed

NCT Number: NCT01152476

Emergency Agitation in T&A

Sevoflurane has been used commonly in pediatric anesthesia since 1990. However, it has caused more emergency agitation (EA) that other inhalation agents and the incidence is up to 80%. Therefore, lower minimum alveolar concentration of sevoflurane will reduce the EA when it is used with remifentanil in pediatric general anesthesia.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

2 year–6 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Seoul National University Bundang Hospital

Seongnam-si, Gyeonggi-do, 463-707, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • American Society of Anesthesiologist physical status I or II
  • 2-6 year-old children
  • patients undergoing tonsillectomy and adenoidectomy

Exclusion criteria

  • upper respiratory disease
  • mental retardation

Treatment and study plan

Remifentanil

Drug

General anesthesia is maintained witn sevoflurane and remifentanil.

normal saline

Drug

General anesthesia is maintained with only sevoflurane and with normal saline instead of remifentanil

Primary outcomes

  1. emergency agitation

    Time frame: during 1 hour after recovering of anesthesia

    at post-anesthetic care unit

Sponsors and collaborators

Lead sponsor

Seoul National University Bundang Hospital

Other

Registry information

Important dates

Study start
2010
Primary completion
2010
Study completion
2010
First posted
Jun 29, 2010
Registry last updated
Jan 6, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.